패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Exploration Score · catalog ranks
Rule-based Catalog Exploration Score for pharmacophore cores and drug/derivative nodes. Not an efficacy prediction.
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.
Core structure exploration tiers
Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.
How similarity is calculated · How clustering works · How exploration priority is scored
치료 영역 · 계열
HighHigh exploration priority2
Highest Exploration Score percentile in this pool (X-S bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| High | Dolastatin 10 / auristatin core MMAE (auristatin) payload family · Scaffold | ADC payload | 100 | 패밀리 core · Pharmacophore · SMILES 확보 · SAR/core | |
| High | Duocarmycin CPI core Duocarmycin CPI ADC payload series · Scaffold | ADC payload | 99 | 패밀리 core · Pharmacophore · SMILES 확보 · SAR/core |
패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
MedMedium exploration priority3
Upper-mid Exploration Score percentile (X-A bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Med | Enediyne warhead core Calicheamicin enediyne payload family · Scaffold | ADC payload | 96 | 패밀리 core · Pharmacophore · SMILES 확보 · SAR/core | |
| Med | PBD monomer (anthramycin lineage) PBD dimer ADC payload family · Scaffold | ADC payload | 96 | 패밀리 core · Pharmacophore · SMILES 확보 · SAR/core | |
| Med | MMAE (monomethyl auristatin E) MMAE (auristatin) payload family · Payload | ADC payload | 91 | Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종 |
패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종
MedMedium exploration priority5
Mid-pool Exploration Score (X-B bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Med | Duocarmycin SA Duocarmycin CPI ADC payload series · Payload | ADC payload | 64 | Payload core · SMILES 확보 · 파생 2건 · 고관심 계열 | |
| Med | MMAF (monomethyl auristatin F) MMAE (auristatin) payload family · Payload | ADC payload | 64 | Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열 | |
| Med | N-acetyl-γ-calicheamicin Calicheamicin enediyne payload family · Payload | ADC payload | 64 | Payload core · SMILES 확보 · 파생 2건 · 고관심 계열 | |
| Med | SG3199 (PBD dimer warhead) PBD dimer ADC payload family · Payload | ADC payload | 64 | Payload core · SMILES 확보 · 파생 2건 · 고관심 계열 | |
| Med | Auristatin E (parent) MMAE (auristatin) payload family · Scaffold | ADC payload | 63 | Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열 |
Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열
Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열
LowLow exploration priority7
Lower Exploration Score — still listed for inspection (X-C bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Low | Calicheamicin γ¹ Calicheamicin enediyne payload family · Payload | ADC payload | 61 | Payload core · SMILES 확보 · 고관심 계열 | |
| Low | Tesirine (SG3249) PBD dimer ADC payload family · Payload | ADC payload | 61 | Payload core · SMILES 확보 · 고관심 계열 | |
| Low | Seco-duocarmycin Duocarmycin CPI ADC payload series · Payload | ADC payload | 56 | Payload core · SMILES 확보 · 고관심 계열 | |
| Low | Val-Cit MMAE (auristatin) payload family · Linker | ADC payload | 55 | Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열 | |
| Low | Acyl hydrazone linker Calicheamicin enediyne payload family · Linker | ADC payload | 52 | Linker hub · SMILES 확보 · 고관심 계열 | |
| Low | Val-Ala PBD linker PBD dimer ADC payload family · Linker | ADC payload | 52 | Linker hub · SMILES 확보 · 고관심 계열 | |
| Low | Duocarmycin Val-Cit linker node Duocarmycin CPI ADC payload series · Linker | ADC payload | 50 | Linker hub · SMILES 확보 · 고관심 계열 |
Payload core · SMILES 확보 · 고관심 계열
Payload core · SMILES 확보 · 고관심 계열
Payload core · SMILES 확보 · 고관심 계열
Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열
Linker hub · SMILES 확보 · 고관심 계열
Linker hub · SMILES 확보 · 고관심 계열
Linker hub · SMILES 확보 · 고관심 계열
Exploration score method
StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.
Core tab
- scaffold / payload / linker role weights
- family center-compound bonus
- SMILES source (db · known · pubchem · inherited)
- relation-edge count and derived-child count
Derivative tab
- drug / derivative / adc candidates
- similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
- approved / clinical catalog-tag bonuses
- ADC / payload tags
Explore tab
- sparse SAR, cross-scaffold pairs, expansion leaves
- weakly linked nodes and approved-tag neighborhood gaps
- relation graph + stored Morgan fingerprints
- category filters
Exploration-priority bins
- High (X-S): top ~12%
- Medium (X-A/X-B): ~12–62%
- Low (X-C): remainder (pools under 5 compounds stay Medium)
Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.
평가 시각: 2026. 9. 11. 오전 4:01:55 · 캐시 5분 · 전체 패밀리